CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-02 | Tammara Vijay Vice President | Grant or award · Options (Right to Buy) | +77,641 | 77,641 | ||
| 2020-01-02 | Subramanian Sanjay Chief Financial Officer | Grant or award · Options (Right to Buy) | +106,774 | 106,774 | ||
| 2020-01-02 | Taspolatoglu Suha Director | Grant or award · Options (Right to Buy) | +54,000 | 54,000 | ||
| 2020-01-02 | Zhang Junge Director | Grant or award · Options (Right to Buy) | +54,000 | 54,000 | ||
| 2020-01-02 | Leo Frank Director | Grant or award · Options (Right to Buy) | +54,000 | 54,000 | ||
| 2020-01-02 | Potti Manish Director | Grant or award · Options (Right to Buy) | +54,000 | 54,000 | ||
| 2020-01-02 | Kompella Uday Director | Grant or award · Options (Right to Buy) | +54,000 | 54,000 | ||
| 2020-01-02 | Kumar Ramesh Director | Grant or award · Options (Right to Buy) | +54,000 | 54,000 | ||
| 2019-12-12 | Musunuri Shankar Chief Executive Officer | Purchase | +143,000 | $0.35 | $50K | 406,000 |
| 2019-12-11 | Musunuri Shankar Chief Executive Officer | Purchase | +263,000 | $0.41 | $108K | 263,000 |
| 2019-12-04 | Zhang Junge Director | Purchase | +220,000 | $0.44 | $97K | 818,578 |
| 2019-11-27 | Zhang Junge Director | Purchase | +270,000 | $0.37 | $100K | 600,078 |
| 2019-11-25 | Zhang Junge Director | Purchase | +115,000 | $0.27 | $31K | 330,078 |
| 2019-11-22 | Zhang Junge Director | Purchase | +80,000 | $0.28 | $22K | 215,078 |
| 2019-11-22 | Subramanian Sanjay Chief Financial Officer | Purchase | +5,000 | $0.28 | $1K | 10,000 |
| 2019-11-18 | Zhang Junge Director | Purchase | +98,500 | $0.41 | $40K | 133,578 |
| 2019-11-18 | Zhang Junge Director | Purchase | +100,000 | $0.41 | $41K | 135,078 |
| 2019-10-11 | Zhang Junge Director | Purchase | +4,000 | $1.48 | $6K | 35,078 |
| 2019-10-02 | Subramanian Sanjay Chief Financial Officer | Purchase | +5,000 | $1.88 | $9K | 5,000 |
| 2019-10-01 | Subramanian Sanjay Chief Financial Officer | Grant or award · Stock Options | +23,970 | 23,970 |
Page 15 of 27 · 525 trades